drugset / Trial / NCT06594224
Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section
RandomizedParallel-groupOpen-labelTreatment
Summary
The local data is insufficient to directly compare IV nalbuphine versus ibuprofen among people in this region. The findings of this study would add to the existing data and would be helpful for health providers to opt for a better option for postoperative pain relief following a cesarean section under general anesthesia.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2024-08-31
- Completion
- 2024-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibuprofen | Small molecule | 800 mg | Intravenous |
| Subject | Nalbuphine | Small molecule | 20 mg | Intravenous |
Indications
No indication recorded.